|
2013 |
New Models for Lung Cancer Research (Year 2 of 2) |
$59,518 |
Lung |
The Jackson Laboratory |
|
|
2013 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$70,501 |
Bone |
University of New England |
|
|
2012 |
New Models for Lung Cancer Research |
$59,518 |
Lung |
The Jackson Laboratory |
|
|
2012 |
Development of a Cancer Staging Tool Based on Viscoelastic and Spectrosphic Properties of Cystic Fluids |
$75,422 |
Screening |
University of Maine Orono |
|
|
2012 |
3DMammoComp: Next Generation Computational Analysis of Breast Tomosynthesis |
$82,843 |
Breast |
University of Maine Orono |
|
|
2012 |
Improving Colorectal Cencer Screenings in Low-Income Primary Care Settings Using Shared Decision Making |
$97,860 |
Screening |
Maine Medical Center |
|
|
2012 |
The Role of IL-6 Signaling in Cancer-induced Bone Pain |
$69,132 |
Bone |
University of New England |
|
|
2012 |
FoxC2 Function in glioma stem cells and Vasculature |
$84,000 |
All |
The Jackson Laboratory |
|
|
2012 |
Feasibility of Using SEER-Medicare Data to Assess the Influence of ESA Policy Changes on Outcomes |
$55,936 |
All |
University of New England |
|
|
2012 |
Inhibitory Effects of Insulin-like Growth Factor Binding Protein-4(IGFBP-4) on Melanoma Growth and Metastasis |
$73,848 |
Skin |
Maine Medical Center |
|
|
2011 |
Notch Regulation of the Tumor Supressor miR-145 in Breast Cancer Cells |
$94,184 |
Breast |
Maine Medical Center |
|
|
2011 |
Small Molecule Inhibitors of Twist1 Function to Inhibit Tumor Progression |
$73,039 |
Molecular |
Maine Medical Center |
|
|
2011 |
Validating Prediction Tools for Prostate Cancer Quality of Life Outcomes |
$71,029 |
Prostate |
Maine Medical Center |
|
|
2011 |
FGF Export from Endothelial Cells: Protumorigenic Potential and Methods of Regulation |
$86,877 |
Cellular |
Maine Medical Center |
|
|
2011 |
Targeted SiRNA Inhibition of Vascular Endothelial Growth Factors in Lung Cancer Cells |
$69,000 |
Lung |
Husson University |
|
|
2011 |
The Molecular Structor of Arm 1 |
$73,087 |
Molecular |
Maine Institue for Human Genetics and Health |
|
|
2011 |
Inceptive Role of miR-199b in Acute Myeloid Leukemia |
$92,000 |
Leukemia |
Maine Medical Center |
|
|
2011 |
Non-Psychotropic Cannabinoid2 Receptor Agonists Inhibit Breast Cancer Proliferation |
$105,197 |
Breast |
University of New England |
|
|
2011 |
Functional Analysis of Foxq1's Role in Tumor Vascularization |
$75,823 |
Molecular |
Mount Desert Biological Laboratory |
|
|
2011 |
Imaging Glicoma Stem Cell Dynamics in Vivo |
$90,000 |
Screening |
The Jackson Laboratory |
|
|
2010 |
Role of Cryptic Activation Site within B1 Integrins in Breast Tumor Growth |
$91,919 |
Breast |
Maine Medical Center Research Institute |
|
|
2010 |
Genetic Chemotherapy: Inducing Leukemia and Lymphoma Cell Self Destruction |
$67,500 |
Leukemia, Lymphoma |
The Jackson Laboratory |
|
|
2010 |
Evaluating MicroRNA's as Prognostic Determinants in Stage II Colon Cancer |
$78,000 |
Colon |
Maine Center for Cancer Medicine |
|
|
2010 |
Computationaal Pathology: 3-d Analysis of Chromosome Territories |
$80,000 |
Screening |
University of Maine Orono |
|
|
2010 |
Noth Signaling in Medulloblastoma Initiation and Cancer Stem Cell Maintenance |
$90,000 |
Cervical, Molecular |
The Jackson Laboratory |
|
|
2010 |
Targeting Stromal Cell Interactions to Reduce Prostate Cancer |
$81,175 |
Prostate |
Maine Medical Center Research Institute |
|
|
2010 |
Regulation of Hematopoietic Stem Cells by Heparin Binding Domain of IGFBP-2 |
$82,535 |
Cellular, Molecular |
Maine Medical Center Research Institute |
|
|
2010 |
MicroRNA Expression during Lung Timor Progression |
$90,000 |
Lung |
The Jackson Laboratory |
|
|
2009 |
Role of MicroRNA-10b in Neurofibromatosis Type 1 Tumorigenesis and Progression |
$72,059 |
Cellular, Molecular |
Maine Institue for Human Genetics and Health |
|
|
2009 |
Validating S100A6 as a Novel Marker and Potential Therapeutic Target of Brain Cancer Stem Cells |
$80,000 |
Brain |
The Jackson Laboratory |
|
|
2009 |
Improved Cancer Detection through the use of Engineered Nanoparticle Bioconjugates |
$78,292 |
Screening |
University of Maine Orono |
|
|
2009 |
Functional Tests of PODXL's Contributions to Tumorigenesis |
$80,000 |
Screening |
Maine Medical Center Research Institute |
|
|
2009 |
Predicting Quality of Life Outcomes after Prostate Cancer Treatment |
$45,295 |
Prostate |
Maine Medical Center |
|
|
2008 |
Homologous Recombination Factor XRCC2 in B-Cell Genome Stability and Tumor Supression |
$79,696 |
Cellular, Molecular |
The Jackson Laboratory |
|
|
2008 |
FGF-Mediated Tumor Growth Induced by Noth Signaling Inhibition |
$86,191 |
Cellular, Molecular |
Maine Medical Center Research Institute |
|
|
2008 |
Wavelet-based image analysis of Mammograms |
$73,552 |
Breast |
University of Maine Orono |
|
|
2008 |
Genetic Model of TGFB Receptor-Dependent Supression of Prostate Cancer Metastasis |
$78,413 |
Prostate |
Maine Medical Center Research Institute |
|
|
2008 |
Role of Delta Opioid Receptors in Bone Cancer |
$81,995 |
Bone |
University of New England |
|
|
2008 |
Development Genomics of Lung Cancer |
$79,524 |
Lung |
The Jackson Laboratory |
|
|
2007 |
Twist dimers as markers of tumor metastasis |
$73,000 |
Screening |
Maine Medical Center Research Institute |
|
|
2007 |
Array-based Comparative Genomic Hybridization of Circulation Tumor Cells in Breast Cancer Patients Before & During Treatment |
$80,000 |
Screening |
Eastern Maine Healthcare Systems |
|
|
2007 |
RECQL4 Protein-Protein Interactions in Human Osteosarcoma Cell Lines |
$71,000 |
Cellular, Molecular |
Eastern Maine Healthcare Systems |
|
|
2007 |
Sprouty 4: a possible repressor of Id protein function in breast cancer |
$72,000 |
Breast |
Maine Medical Center Research Institute |
|
|
2006 |
Reduction of breast cancer by the Notch signaling pathway |
$35,000 |
Breast |
Maine Medical Center |
|
|
2006 |
Preventive and Therapeutic Effects of Vitamin D3 an its Membrane Receptor on Neoplastic Cells |
$76,206 |
Screening |
University of Maine Orono |
|
|
2006 |
Chromatin Reorganization in Pro-B Cell Lymphoma Nuclei |
$74,180 |
Lymphoma |
The Jackson Laboratory |
|
|
2006 |
Molecular Predictors of Iressa Response in Lung Cancer Patients |
$68,241 |
Lung |
Maine Center for Cancer Medicine |
|
|
2006 |
The Role of Src Kinases in Regulation of Stem Cell Survival in CML |
$75,000 |
Cellular |
The Jackson Laboratory |
|